Clinic and Computed Tomographic Imaging of Lung Pathology in COVID-19 Comorbidity, Tuberculosis and Opportunistic Diseases in Patients with HIV Infection

The clinic and computer tomographic imaging of lung pathology in COVID-19 comorbidity, tuberculosis and opportunistic diseases in patients with stage IV of HIV infection, in the phase of progression, in the absence of ART in 29 patients compared with similar 29 patients, but without COVID-19 were studied. It was found that the comorbidity of COVID-19 and tuberculosis, stage IV of HIV infection, in the phase of progression, in the absence of ART is characterized by the generalization of tuberculosis and the development of opportunistic lung diseases, severe clinical picture and visualization with computed tomography of dissemination syndrome, pulmonary pattern pathology and adenopathy, which practically does not differ from patients without COVID-19. It is not possible to diagnose this comorbidity by clinical and radiation methods of research. Special microbiological and molecular genetic methods are needed to study diagnostic material from the respiratory system and other organs in order to prescribe timely etiological treatment.

1. Belyakov N. A., Rassokhin V. V., Trofimova T. N., Stepanova E. V., Panteleev A. M., Leonov O. N., Buzunova S. A., Konovalova N. V., Milichkina A. M., Totolyan A. A. Comorbid and severe forms of HIV infection in Russia. HIV infection and immu no sup pression. 2016. V. 8. No. 3. P. 9–25 (in Russian). https://doi.org/10.22328/2077-9828-2016-8-3-9-25

2. Temporary methodological recommendations of the Ministry of Health of the Russian Federation. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 13-1 (11.17.2021). 235 p (in Russian).

3. Gauss A. A., Klimova N. V. Rentgenomorphological features of the course of COVID-19 and HIV infection. HIV infection and immunosuppression. 2021. V. 13. No. 2. P. 77–84 (in Russian). http://dx.doi.org/10.22328/2077-9828-2021-13-2-77-84

4. Clinical recommendations — HIV infection in adults. 2020 (16.02.2021). Approved by the Ministry of Health of the Russian Federation. 97 p. (in Russian).

5. Kravchenko A. V., Kuimova U. A., Kanestri V. G., Goliusova M. D., Kulabukhova E. I. Clinical course and approaches to therapy of patients with combined infection (HIV infection and COVID-19). Epidemiology and infectious diseases. 2021. No. 4. P. 20–24 (in Russian). https://dx.doi.org/10.18565/epidem.2021.11.4.20-4

6. Mishina A. V., Mishin V. Yu., Ergeshov A. E., Sobkin A. L., Romanov V. V., Kononets A. S. Features of clinical manifestations and diagnosis of combination of respiratory tuberculosis with opportunistic lung infections in adult patients with late stages of HIV infection with immunodeficiency. CONSILIUM Medicum. 2020. V. 22. No. 11. P. 78–86 (in Russian). https://doi.org/10.442120751753.2020.11.200184

7. Starshinova A. A. Dovgalyuk I. F. Tuberculosis in the structure of comorbid pathology in patients with COVID-19. Pacific Journal. 2021. No. 1. P. 1609–1175. (in Russian). https://doi:10.34215/1609-1175-2021-1-10-14

8. Federal clinical guidelines for the diagnosis and treatment of tuberculosis in patients with HIV infection. M.–Tver: Publishing house «Triad». 2014. 56 p. (in Russian).

9. Bartlett G., Redfield R., Pham P. Bartlett’s Medical Management of HIV Infection. Oxford Univercity Press. 2019. 864 p. https://doi:10.1093/med/9780190924775.001.0001

10. Cabelloa A., Zamarroa B., Nistalb S., Victorc V., Hernándezd J., Prieto-Péreza L., Carrilloa I., Álvareza B., Fernández-Roblase R., Hernández-Seguradof M., Becaresf J., Benitog J. M., Rallóng N., Téllezh R., Castañoh Á. L., Herreroi A., Górgolasa M. COVID-19 in people living with HIV: A multicenter case-series study. International J. of Infectious Diseases. September 2021. 102. P. 310–315. http://doi:creativecommons.org/licenses/by-nc-nd/4.0/

11. Faqihi F., Alharthy A., Noor A., Balshi A., Balhamar A., Karakitsos D. COVID-19 in a patient with active tuberculosis: A rare case-report RSS. Respiratory Medicine Case Reports. 2020. P. 31. https://doi.org/10.1016/j.rmcr.2020.101146

12. Hoffmann C., Casado J. L., Härter G., Vizcarra P., Moreno A., Cattaneo D., Meraviglia Р., Christoph D., Schabaz F., Grunwald S., Gervasoni C. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Medicine. 2021 May. V. 22. No. 5. P. 372–378. http://doi.org/10.1111/hiv.13037

13. Jiang H,, Zhou Y,, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020 May. V. 7. No. 5. P. 308–309. https://doi:10.1016/S2352-3018(20)30105-3

14. Shiau S., Krause D., Valera P., Swaminathan S., Halkitis P., Halkitis P. The Bur den of COVID-19 in People Living with HIV: A Syndemic Perspective. Nature Pub lic Health Emergency Collection. 2020 Apr 18. P. 1–6. https://doi:10.1007/s10461-020-02871-9

15. Stochino C., Villa S., Zucchi P., Parravicini P., Gori A., Raviglione M. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. EurRespir J. 2020. V. 56. No. 1. P. 200–217. https://doi:10.1183/13993003.017082020